GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (HKSE:01093) » Definitions » Policy Acquisition Expense

CSPC Pharmaceutical Group (HKSE:01093) Policy Acquisition Expense


View and export this data going back to 1994. Start your Free Trial

What is CSPC Pharmaceutical Group Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


CSPC Pharmaceutical Group Business Description

Address
No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.
Executives
Ubs Group Ag 2201 Interest of corporation controlled by you
Cai Dong Chen 2201 Interest of corporation controlled by you
Citigroup Inc. 2502 Approved lending agent
Blackrock, Inc. 2201 Interest of corporation controlled by you
True Ally Holdings Limited 2201 Interest of corporation controlled by you
Gong Cheng Guo Ji You Xian Gong Si 2101 Beneficial owner
Ding Da Ji Tuan You Xian Gong Si 2101 Beneficial owner